Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Endocrinology|July 14, 2011
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patientsMaria Grazia Castagna, Fabio Maino, Claudia Cipri, et al.
Frontiers in Endocrinology|June 2, 2012
Effects of Acute Recombinant Human TSH on Serum Ghrelin LevelsCristina Ciuoli, Lucia Brusco, Alexandra Theodoropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2009
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patientsHernan P Tala Jury, Maria Grazia Castagna, Carla Fioravanti, et al.
International Journal of Molecular Sciences|April 7, 2017
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) DiagnosisSilvia Cantara, Carlotta Marzocchi, Tania Pilli, et al.
Thyroid : Official Journal of the American Thyroid Association|November 9, 2010
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditisSerenella Checchi, Annalisa Montanaro, Cristina Ciuoli, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2007
L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodiesSerenella Checchi, Annalisa Montanaro, Letizia Pasqui, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancerFerruccio Santini, Valeria Bottici, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodiesSerenella Checchi, Annalisa Montanaro, Letizia Pasqui, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian populationSilvia Cantara, Tania Pilli, Guido Sebastiani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patientsRossella Elisei, Agnese Vivaldi, Laura Agate, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Endocrinology|July 14, 2011
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patientsMaria Grazia Castagna, Fabio Maino, Claudia Cipri, et al.
Frontiers in Endocrinology|June 2, 2012
Effects of Acute Recombinant Human TSH on Serum Ghrelin LevelsCristina Ciuoli, Lucia Brusco, Alexandra Theodoropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2009
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patientsHernan P Tala Jury, Maria Grazia Castagna, Carla Fioravanti, et al.
International Journal of Molecular Sciences|April 7, 2017
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) DiagnosisSilvia Cantara, Carlotta Marzocchi, Tania Pilli, et al.
Thyroid : Official Journal of the American Thyroid Association|November 9, 2010
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditisSerenella Checchi, Annalisa Montanaro, Cristina Ciuoli, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2007
L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodiesSerenella Checchi, Annalisa Montanaro, Letizia Pasqui, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancerFerruccio Santini, Valeria Bottici, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodiesSerenella Checchi, Annalisa Montanaro, Letizia Pasqui, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian populationSilvia Cantara, Tania Pilli, Guido Sebastiani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patientsRossella Elisei, Agnese Vivaldi, Laura Agate, et al.
Pageof 15